CATHERINE GARAGOZZO: Open Payments
NPI 1477331569 · CONROE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,160 in 147 payments from 21 companies in 2025. Trend: 2023 $536 · 2024 $4,419 · 2025 $3,160
Food & beverage: $3,160
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $545 |
| Regeneron Healthcare Solutions, Inc. | 11 | $305 |
| Novartis Pharmaceuticals Corporation | 21 | $305 |
| GENZYME CORPORATION | 10 | $298 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $255 |
| Galderma Laboratories, L.P. | 14 | $228 |
| Arcutis Biotherapeutics, Inc. | 2 | $208 |
| Lilly USA, LLC | 11 | $205 |
| UCB, Inc. | 6 | $203 |
| Amgen Inc. | 6 | $122 |
Products named: DUPIXENT, SKYRIZI, COSENTYX, ILUMYA, Zoryve, Bimzelx, TALTZ, RINVOQ.
Industry payments across TX — which companies pay providers there.
